The shift towards proactive health management and personalized wellness is fueling unprecedented demand for unobtrusive, continuous health monitoring. Consumers expect wearable devices to be comfortable, accurate, and seamlessly integrated into daily life, pushing manufacturers to innovate beyond current limitations. Simultaneously, healthcare systems are increasingly adopting remote monitoring solutions to manage chronic conditions and reduce hospitalizations, creating a robust market for advanced bio-sensing technologies. This technology provides a critical competitive edge by enabling superior user experience and data quality.
Achieves exceptional bio-conformability, potentially offering approximately 3 times the flexibility of conventional rigid electrodes to follow skin movements.
Ensures long-term stable measurement and comfort by preventing skin irritation through gas and moisture permeability, reducing re-measurement risk due to errors by approximately 25%.
Enables rapid market entry and exclusive advantage, supported by only two cited prior art documents, indicating high uniqueness and potential for early market share in a blue ocean segment. Protected until 2041.
This patent protects a highly unique and technically superior electrode structure, having successfully overcome two office actions with precise amendments. This indicates robust and stable intellectual property rights with a low risk of invalidation, providing licensees with a secure foundation for business development.
This patent primarily protects the electrode's physical structure and material composition. White space exists in developing advanced AI-driven diagnostic algorithms for the collected bio-data or integrating these electrodes into novel therapeutic delivery systems.
Improved measurement accuracy could reduce re-examination costs caused by erroneous readings. Assuming annual medical personnel and consumable costs for re-examinations are ~$330K (AI est.), this technology could reduce the error rate by 25% (~$80K/year, AI est.). Including reduced device replacement frequency and opportunity cost savings from shorter development cycles, the total economic impact is estimated at ~$1M per year per facility (AI est.).
X: Wearability Comfort & Biocompatibility
Y: Long-Term Measurement Stability & Accuracy